Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti PD-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05816746
What this trial is testing

Decitabine and Anti-PD-1 in R/R DLBCL

Who this might be right for
Diffuse Large B Cell LymphomaRelapse/RecurrenceExtranodal Extension+1 more
Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05426005
What this trial is testing

Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer Stage IVMismatch Repair-deficient (dMMR)Microsatellite Instability-high (MSI-H)
Sun Yat-sen University 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05787613
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of HLX26 (Anti-LAG-3 Monoclonal Antibody Injection) Combined With Serplulimab and Chemotherapy in Previously Untreated Advanced NSCLC Patients

Who this might be right for
NSCLC Stage IV
Shanghai Henlius Biotech 132
Not applicableLooking for participantsNCT06285188
What this trial is testing

Immunomonitoring of Mold Invasive Infections

Who this might be right for
Invasive Fungal DiseaseMold Invasive Fungal Infection: Aspergillus, Mucorales, Fusarium, Scedosporium
Assistance Publique - Hôpitaux de Paris 20
Testing effectiveness (Phase 2)Study completedNCT03767582
What this trial is testing

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Large-scale testing (Phase 3)Looking for participantsNCT03651206
What this trial is testing

Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib

Who this might be right for
Ovarian CarcinosarcomaEndometrial Carcinosarcoma
ARCAGY/ GINECO GROUP 138
Testing effectiveness (Phase 2)Ended earlyNCT04899921
What this trial is testing

Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets

Who this might be right for
MelanomaMetastatic Melanoma
Dana-Farber Cancer Institute 1
Not applicableUnknownNCT05349045
What this trial is testing

Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
The First Affiliated Hospital of Zhengzhou University 300
Testing effectiveness (Phase 2)UnknownNCT03827837
What this trial is testing

Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors

Who this might be right for
Renal Cell CarcinomaUrothelial CarcinomaCervical Cancer+2 more
Jiangsu HengRui Medicine Co., Ltd. 265
Early research (Phase 1)Looking for participantsNCT05422794
What this trial is testing

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Locally Advanced Triple-Negative Breast Carcinoma+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT04326257
What this trial is testing

Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Dan Zandberg 20
Early research (Phase 1)Study completedNCT02936752
What this trial is testing

Testing the Safety and Efficacy of the Combination of the Antibody Pembrolizumab and Entinostat in Patients With Myelodysplastic Syndrome Who Are Not Responding to Hypomethylating Agents

Who this might be right for
Myelodysplastic Syndrome
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Looking for participantsNCT06642792
What this trial is testing

AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma

Who this might be right for
Classic Hodgkin Lymphoma
Akeso 280
Testing effectiveness (Phase 2)Ended earlyNCT04069936
What this trial is testing

Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC

Who this might be right for
Non Small Cell Lung CancerLung CancerLung Cancer Metastatic+5 more
WindMIL Therapeutics 19
Testing effectiveness (Phase 2)UnknownNCT05723432
What this trial is testing

KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Shanghai Kanda Biotechnology Co., Ltd. 84
Testing effectiveness (Phase 2)Study completedNCT03240016
What this trial is testing

Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
University of Michigan Rogel Cancer Center 36
Testing effectiveness (Phase 2)UnknownNCT05964101
What this trial is testing

Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma

Who this might be right for
NeoplasmsCarcinoma, SquamousAntineoplastic Agents
The First Affiliated Hospital of Guangzhou Medical University 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05529316
What this trial is testing

Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma

Who this might be right for
Advanced Melanoma
Agenus Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT03387111
What this trial is testing

QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed

Who this might be right for
Squamous Cell Carcinoma
ImmunityBio, Inc. 4
Not applicableUnknownNCT06423144
What this trial is testing

PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 150
Next Page
57